Not every company we research ends up in the portfolio. Sometimes the most important part of the job is knowing when to walk away.
It’s rarely one bad number that does it. A weak quarter can have a reasonable explanation. But when a few things start going wrong at the same time, we start asking harder questions.
Here’s what usually makes us say no: a balance sheet that keeps getting weaker, no clear sense of what will drive growth next, management that keeps promising more than it delivers, one capital raise too many, a company wandering into businesses it has no business being in, and profits that look good on paper but never really show up as cash.
Before we commit capital, we go back to the basics: can the balance sheet support growth, what will actually drive the next leg, does management do what it says, is shareholder capital being used well, and are the profits real in cash terms.
It’s easy to find reasons to buy when a story sounds exciting. Investing is as much about knowing what you won’t ignore.
Disclaimer: PMS investments are subject to market risks. For risk factors, investment details, and important disclosures, please visit our website.
www.carepms.com
